Navigation Links
Experimental Pill for Multiple Sclerosis Shows Promise
Date:4/16/2012

ant for people with MS to have access to a variety of options for safe and effective therapies."

"Based on this phase 2 study, ONO-4641 appears promising and so we look forward to the results of larger studies of this new agent," he said.

Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.

More information

To learn more about MS, visit the National Multiple Sclerosis Society.

SOURCES: Timothy Vollmer, M.D., professor, neurology and medical director, Rocky Mountain MS Center, University of Colorado, Denver; Gary Birnbaum, M.D., director, Multiple Sclerosis Treatment and Research Center, Minneapolis Clinic of Neurology, Minneapolis; Nicholas LaRocca, Ph.D., vice president for health care delivery and policy research, National MS Society; April 16, 2012, presentation, American Academy of Neurology's 64th Annual Meeting, New Orleans


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Experimental Pill May Ease Multiple Sclerosis Disability
3. Experimental Drug Shows Promise Against Cushings Disease
4. Experimental Drug Offers Hope for Rare Bone Disease: Study
5. Experimental Drug Shows Promise Against Type 2 Diabetes
6. First-in-human drug for malignant glioma available in experimental trial
7. Experimental Drug Might Beat Aspirin in Preventing Repeat Strokes: Study
8. Experimental Drugs Do Battle Against Advanced Prostate Cancer
9. Experimental Blood Thinner Given Before Surgery Shows Benefit
10. Wolfson Foundation awards £20 million to UCL for experimental neurology center
11. Novel experimental agent is highly active in CLL patients, interim study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Pill for Multiple Sclerosis Shows Promise
(Date:4/18/2014)... published online in The Gerontologist ... is associated with a decrease in anxiety about death ... control over their lives. In particular, listening to gospel ... death and an increase in sense of control. , ... and men, and individuals of both low- and high-socioeconomic ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2
... Caring World Experience Features High Tech, Interactive Exhibits, ... (NYSE:,JNJ), Worldwide Partner of the International Olympic Committee ... Paralympic Games, today unveiled,its Olympic Games Pavilion on ... World exhibition, which illustrates the company,s commitment to,caring ...
... Aurora Health Care,has been honored as YMCA of ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080806/AQW060 ), "As Black Achievers, ... Marsha Lee, Black Achievers director at the YMCA ... pursue and set high educational and career goals.", ...
... 6 The thoughts and support of the entire,Susan ... Applegate as she,undergoes treatment for breast cancer., (Logo: ... supporter of Susan G. Komen for the Cure,having championed ... over the years. As the daughter of a breast ...
... System Improves Patient Care, ATLANTA, Aug. ... announced the launch of its new WellCentive,Outreach ... Voice Over,Internet Protocol (VoIP) technology. The WellCentive ... about upcoming,appointments or overdue care, such as ...
... doctors informing patients of this simple preventive approach, study says ... reduce the risk of colon cancer, but few American adults ... sedentary lifestyle accounts for as many as 14 percent of ... get lots of exercise have a 30 percent to 40 ...
... aphasia in Alzheimer,s disease and related forms of dementia following initiation ... related to immune regulation of brain function, providing an exciting new ... ... (PRWEB) August 5, 2008 -- Rapid improvement of aphasia and word-finding ...
Cached Medicine News:Health News:Johnson & Johnson Unveils Olympic Games Pavilion Featuring Authentic Qin Shi Huang Terracotta Warrior Exhibit 2Health News:Johnson & Johnson Unveils Olympic Games Pavilion Featuring Authentic Qin Shi Huang Terracotta Warrior Exhibit 3Health News:Aurora Health Care Employee Named YMCA Black Achiever of the Year 2Health News:Susan G. Komen for the Cure(R) Comments on Christina Applegate's Breast Cancer Diagnosis 2Health News:WellCentive Launches the WellCentive Outreach System 2Health News:WellCentive Launches the WellCentive Outreach System 3Health News:Exercise Lowers Risk of Colon Cancer 2Health News:New Drug May Help Combat Alzheimer's 2Health News:New Drug May Help Combat Alzheimer's 3
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Novagali Pharma, an,emerging pharmaceutical company specialized in ophthalmology,presents ... trial,positive results from the Phase III clinical study ... at the,XIV Afro-Asian Congress of ophthalmology (AACO) held ... , VKC is a severe form of chronic ...
... Interim results in a randomized phase II/III ... 26, 2007 /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) ... that treatment with pixantrone (BBR,2778) resulted in ... mitoxantrone induced significant cardiac damage.,The studies compared ...
Cached Medicine Technology:Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
... Recently updated with a high resolution ... new Kowa Non Myd - digital ... style and ease of use. Now ... easy to install VK-2 image and ...
... 2000 incorporates a full ... programs in precisely evaluating ... is a full-function, state-of-art ... efficient acquisition, storage, retrieval ...
Nidek LM-990A accomplishes precise measurement, quick response and easy operation....
Autolensmeter with black/white monitor and no internal printer....
Medicine Products: